These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28189403)
1. Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV). Jarrahian C; Rein-Weston A; Saxon G; Creelman B; Kachmarik G; Anand A; Zehrung D Vaccine; 2017 Mar; 35(14):1789-1796. PubMed ID: 28189403 [TBL] [Abstract][Full Text] [Related]
2. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan. Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Oberste MS; Sutter RW; Zaidi AKM Vaccine; 2017 May; 35(24):3209-3214. PubMed ID: 28479178 [TBL] [Abstract][Full Text] [Related]
3. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba. Resik S; Tejeda A; Mach O; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter R Vaccine; 2015 Jan; 33(2):307-13. PubMed ID: 25448109 [TBL] [Abstract][Full Text] [Related]
4. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults. Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332 [TBL] [Abstract][Full Text] [Related]
5. Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization. Okayasu H; Sein C; Chang Blanc D; Gonzalez AR; Zehrung D; Jarrahian C; Macklin G; Sutter RW J Infect Dis; 2017 Jul; 216(suppl_1):S161-S167. PubMed ID: 28838185 [TBL] [Abstract][Full Text] [Related]
6. Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis. Jaiswal N; Singh S; Agarwal A; Chauhan A; Thumburu KK; Kaur H; Singh M Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011780. PubMed ID: 31858595 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine. Mvundura M; Hsu JS; Frivold C; Kristensen D; Boyle S; Zehrung D; Jarrahian C Vaccine X; 2019 Aug; 2():100032. PubMed ID: 31384747 [TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia. Clarke E; Saidu Y; Adetifa JU; Adigweme I; Hydara MB; Bashorun AO; Moneke-Anyanwoke N; Umesi A; Roberts E; Cham PM; Okoye ME; Brown KE; Niedrig M; Chowdhury PR; Clemens R; Bandyopadhyay AS; Mueller J; Jeffries DJ; Kampmann B Lancet Glob Health; 2016 Aug; 4(8):e534-47. PubMed ID: 27364568 [TBL] [Abstract][Full Text] [Related]
9. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity. Resik S; Tejeda A; Mach O; Sein C; Molodecky N; Jarrahian C; Saganic L; Zehrung D; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter RW Vaccine; 2015 Oct; 33(43):5873-5877. PubMed ID: 26192350 [TBL] [Abstract][Full Text] [Related]
10. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. Anand A; Zaman K; Estívariz CF; Yunus M; Gary HE; Weldon WC; Bari TI; Steven Oberste M; Wassilak SG; Luby SP; Heffelfinger JD; Pallansch MA Vaccine; 2015 Nov; 33(48):6816-22. PubMed ID: 26476367 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule. Anand A; Molodecky NA; Pallansch MA; Sutter RW Vaccine; 2017 May; 35(22):2993-2998. PubMed ID: 28434691 [TBL] [Abstract][Full Text] [Related]
12. Feasibility of jet injector use during inactivated poliovirus vaccine house-to-house vaccination campaigns. Farag NH; Mansour Z; Torossian L; Said R; Snider CJ; Ehrhardt D Vaccine; 2018 Aug; 36(32 Pt B):4935-4938. PubMed ID: 29980387 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults. Troy SB; Kouiavskaia D; Siik J; Kochba E; Beydoun H; Mirochnitchenko O; Levin Y; Khardori N; Chumakov K; Maldonado Y J Infect Dis; 2015 Jun; 211(12):1969-76. PubMed ID: 25567841 [TBL] [Abstract][Full Text] [Related]
15. Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability. Daly C; Molodecky NA; Sreevatsava M; Belayneh AD; Chandio SA; Partridge J; Shaikh A; Laghari M; Agbor J; Safdar RM; Bullo UF; Malik SM; Mahamud A Vaccine; 2020 Feb; 38(8):1893-1898. PubMed ID: 31983581 [TBL] [Abstract][Full Text] [Related]
16. Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia. Bashorun AO; Badjie Hydara M; Adigweme I; Umesi A; Danso B; Johnson N; Sambou NA; Fofana S; Kanu FJ; Jeyaseelan V; Verma H; Weldon WC; Oberste MS; Sutter RW; Jeffries D; Wathuo M; Mach O; Clarke E Lancet Glob Health; 2022 Feb; 10(2):e257-e268. PubMed ID: 34951974 [TBL] [Abstract][Full Text] [Related]
17. Intradermal fractional dose inactivated polio vaccine: a review of the literature. Nelson KS; Janssen JM; Troy SB; Maldonado Y Vaccine; 2012 Jan; 30(2):121-5. PubMed ID: 22100886 [TBL] [Abstract][Full Text] [Related]
18. Quantification of COVID-19 Vaccine Needle and Syringe Dead Space Volumes. Smith DM; Weiss SL; White KM Cureus; 2021 Oct; 13(10):e18969. PubMed ID: 34812330 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial. Snider CJ; Zaman K; Estivariz CF; Yunus M; Weldon WC; Wannemuehler KA; Oberste MS; Pallansch MA; Wassilak SG; Bari TIA; Anand A Lancet; 2019 Jun; 393(10191):2624-2634. PubMed ID: 31104832 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial. Bandyopadhyay AS; Gast C; Rivera L; Sáez-Llorens X; Oberste MS; Weldon WC; Modlin J; Clemens R; Costa Clemens SA; Jimeno J; Rüttimann R Lancet Infect Dis; 2021 Apr; 21(4):559-568. PubMed ID: 33284114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]